Romosozumab for the treatment of osteoporosis – a systematic review
Journal of Endocrinological Investigation · 02.11.2024 · 48 (3) · 547-572
DOI: 10.1007/s40618-024-02469-1 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Endocrinological Investigation, online erschienen am 02.11.2024. Verfasst von V-N Mäkinen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. vivmaa@rm.dk. Hauptthemen laut MEDLINE: Osteoporosis, Antibodies, Monoclonal, Bone Density Conservation Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. vivmaa@rm.dk.
- Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Oregon Osteoporosis Center, Portland, OR, USA.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Zitieren
APA
Mäkinen, V. N., Sølling, A. S., McClung, M., & Langdahl, B. L. (2024). Romosozumab for the treatment of osteoporosis – a systematic review. Journal of Endocrinological Investigation, 48(3), 547-572. https://doi.org/10.1007/s40618-024-02469-1
Vancouver
Mäkinen VN, Sølling AS, McClung M, Langdahl BL. Romosozumab for the treatment of osteoporosis – a systematic review. Journal of Endocrinological Investigation. 2024;48(3):547-572. doi:10.1007/s40618-024-02469-1
BibTeX
@article{Mkinen2024,
author = {Mäkinen, V-N and Sølling, A S and McClung, M and Langdahl, B L},
title = {Romosozumab for the treatment of osteoporosis – a systematic review},
journal = {Journal of Endocrinological Investigation},
year = {2024},
volume = {48},
number = {3},
pages = {547--572},
doi = {10.1007/s40618-024-02469-1}
}
EUVIMED